Clinical trial
Randomized Phase II Clinical Study of Radiation Therapy, Hormone Therapy and Chemotherapy With Docetaxel Versus Radiation Therapy and Hormone Therapy in Patients With High-Risk Localized Prostate Cancer (Stage III and IV)"
NCT03432780 is registered in ClinicalTrials.gov with Spanish Oncology Genito-Urinary Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Phase II Clinical Study of Radiation Therapy, Hormone Therapy and Chemotherapy With Docetaxel Versus Radiation Therapy and Hormone Therapy in Patients With High-Risk Localized Prostate Cancer (Stage III and IV)"
- Lead sponsor
- Spanish Oncology Genito-Urinary Group
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 18, 2008
- Completion date
- November 14, 2023
- Enrollment
- 134 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer stage iii, prostate cancer stage iv